Literature DB >> 10206471

Regulation of oligodendrocyte development.

D M Orentas1, R H Miller.   

Abstract

Oligodendrocytes are the cells responsible for the formation of myelin in the central nervous system. Recent studies demonstrated that cells of the oligodendrocyte lineage initially arise in distinct regions of the ventricular zone during early development. These cells or their progeny migrate to developing white matter tracts where they undergo the majority of their proliferation and subsequently differentiate into myelinating cells. Oligodendrocyte-precursor cell proliferation is regulated by a number of distinct growth factors that act at distinct stages in the lineage and the final number of oligodendrocytes in any region of the CNS is regulated by local influences. A density-dependent feedback inhibition of proliferation reduces the responsiveness of the cells to their growth factors and the final matching of oligodendrocyte and axon number is accomplished through the local regulation of cell death. In this review, we discuss the major factors that regulate three distinct stages in the development of the oligodendrocyte lineage: The initial induction of oligodendrocyte progenitors, the regulation of expansion and dispersion of the committed precursor cell population, and the final regulation of oligodendrocyte precursor number through the local inhibition of oligodendrocyte precursor proliferation and cell death.

Mesh:

Substances:

Year:  1998        PMID: 10206471     DOI: 10.1007/BF02741302

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  88 in total

1.  Platelet-derived growth factor is mitogenic for O-2Aadult progenitor cells.

Authors:  G Wolswijk; P N Riddle; M Noble
Journal:  Glia       Date:  1991       Impact factor: 7.452

2.  Astrocytes and O-2A progenitors migrate toward distinct molecules in a microchemotaxis chamber.

Authors:  R Armstrong; L Harvath; M Dubois-Dalcq
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Oligodendrocyte precursors originate from both the dorsal and the ventral parts of the spinal cord.

Authors:  P Cameron-Curry; N M Le Douarin
Journal:  Neuron       Date:  1995-12       Impact factor: 17.173

4.  FGF modulates the PDGF-driven pathway of oligodendrocyte development.

Authors:  R D McKinnon; T Matsui; M Dubois-Dalcq; S A Aaronson
Journal:  Neuron       Date:  1990-11       Impact factor: 17.173

Review 5.  Cellular and molecular aspects of myelin protein gene expression.

Authors:  A T Campagnoni; W B Macklin
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

6.  Oligodendrocyte precursor quantitation and localization in perinatal brain using a retrospective bioassay.

Authors:  G E Gonye; A E Warrington; J A DeVito; S E Pfeiffer
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

7.  Requirement of polysialic acid for the migration of the O-2A glial progenitor cell from neurohypophyseal explants.

Authors:  C Wang; G Rougon; J Z Kiss
Journal:  J Neurosci       Date:  1994-07       Impact factor: 6.167

8.  Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts.

Authors:  A E Warrington; E Barbarese; S E Pfeiffer
Journal:  J Neurosci Res       Date:  1993-01       Impact factor: 4.164

9.  Effect of the notochord on proliferation and differentiation in the neural tube of the chick embryo.

Authors:  H W van Straaten; J W Hekking; J P Beursgens; E Terwindt-Rouwenhorst; J Drukker
Journal:  Development       Date:  1989-12       Impact factor: 6.868

10.  PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage.

Authors:  N P Pringle; H S Mudhar; E J Collarini; W D Richardson
Journal:  Development       Date:  1992-06       Impact factor: 6.868

View more
  7 in total

1.  Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function.

Authors:  L A Pasquini; V Millet; H C Hoyos; J P Giannoni; D O Croci; M Marder; F T Liu; G A Rabinovich; J M Pasquini
Journal:  Cell Death Differ       Date:  2011-05-13       Impact factor: 15.828

2.  Long-term disorders of behavior in rats induced by administration of tumor necrosis factor during early postnatal ontogenesis.

Authors:  O E Zubareva; V M Klimenko
Journal:  Neurosci Behav Physiol       Date:  2008-12-17

3.  Endothelin-1 regulates oligodendrocyte development.

Authors:  Ana Gadea; Adan Aguirre; Tarik F Haydar; Vittorio Gallo
Journal:  J Neurosci       Date:  2009-08-12       Impact factor: 6.167

4.  Small Molecule Induction of Human Umbilical Stem Cells into MBP-positive Oligodendrocytes in a Defined Three-Dimensional Environment.

Authors:  Hedvika Davis; Xiufang Guo; Stephen Lambert; Maria Stancescu; James J Hickman
Journal:  ACS Chem Neurosci       Date:  2011-11-29       Impact factor: 4.418

5.  Decreased Neuron Density and Increased Glia Density in the Ventromedial Prefrontal Cortex (Brodmann Area 25) in Williams Syndrome.

Authors:  Linnea Wilder; Kari L Hanson; Caroline H Lew; Ursula Bellugi; Katerina Semendeferi
Journal:  Brain Sci       Date:  2018-11-29

6.  Environmental enrichment ameliorates perinatal brain injury and promotes functional white matter recovery.

Authors:  Thomas A Forbes; Evan Z Goldstein; Jeffrey L Dupree; Beata Jablonska; Joseph Scafidi; Katrina L Adams; Yuka Imamura; Kazue Hashimoto-Torii; Vittorio Gallo
Journal:  Nat Commun       Date:  2020-02-19       Impact factor: 14.919

7.  Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers.

Authors:  Angelika Mühlebner; Jackelien van Scheppingen; Andrew de Neef; Anika Bongaarts; Till S Zimmer; James D Mills; Floor E Jansen; Wim G M Spliet; Pavel Krsek; Josef Zamecnik; Roland Coras; Ingmar Blumcke; Martha Feucht; Theresa Scholl; Victoria-Elisabeth Gruber; Johannes A Hainfellner; Figen Söylemezoğlu; Katarzyna Kotulska; Lieven Lagae; Anna C Jansen; David J Kwiatkowski; Sergiusz Jozwiak; Paolo Curatolo; Eleonora Aronica
Journal:  J Neuropathol Exp Neurol       Date:  2020-10-01       Impact factor: 3.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.